SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-004495
Filing Date
2024-01-08
Accepted
2024-01-08 16:42:54
Documents
15
Period of Report
2024-01-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d685544d8k.htm   iXBRL 8-K 30453
2 EX-10.1 d685544dex101.htm EX-10.1 162646
3 EX-99.1 d685544dex991.htm EX-99.1 11977
7 GRAPHIC g685544page001.jpg GRAPHIC 2405
  Complete submission text file 0001193125-24-004495.txt   389303

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bttx-20240103.xsd EX-101.SCH 2891
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bttx-20240103_lab.xml EX-101.LAB 18736
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bttx-20240103_pre.xml EX-101.PRE 11734
9 EXTRACTED XBRL INSTANCE DOCUMENT d685544d8k_htm.xml XML 3490
Mailing Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101
Business Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101 415-887-2311
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39864 | Film No.: 24520734
SIC: 8000 Services-Health Services
(CF Office: 08 Industrial Applications and Services)